Evidence-Based Chinese Medicine and Technology Assessment (EBCMTA)

The journal aims to promote the development of Chinese medicine and integrative medicine and to improve the science of medical decision-making, as well as to provide high-quality evidence for the use of Chinese medicine in health care services focusing on integrative medicine to enhance the standardization and normalization for healthcare system. The journal receives submissions from multiple disciplines in relation to evidence-based medicine in Chinese medicine and integrative medicine, which cover the following areas: (1) Methodology and techniques: Methodological research on Chinese medicine and integrative medicine in therapeutic evaluation, evidence grading and evaluation, techniques of GRADE methods in guideline development, development of clinical evaluation scales, disease risk and intervention prediction models, artificial intelligence and its application; (2) Evidence synthesis: Systematic review/meta-analysis, bibliometric studies and visualization analysis; (3) Standards & norms: Clinical practice guidelines, clinical pathways, and expert consensus; (4) Technology assessment: technology assessment (target disease for a treatment scheme research, medical technology assessment, screening and application of technology), pharmacoeconomic studies; (5) Evidence-based decision-making: evidence-based clinical practice, evidence-based public health, evidence-based policy making, and clinical audit; (6) Evidence-based clinical studies: generation of reliable evidence such as clinical trials, mixed methods research, health services research, implementation research.

Evidence-Based Chinese Medicine and Technology Assessment (EBCMTA) is :-

• International, Peer-Reviewed, Open Access, Refereed, health care , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 3078-7963, Established: 2024,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE